CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $13,000 | -13.3% | 5,198 | 0.0% | 0.00% | – |
Q2 2021 | $15,000 | -6.2% | 5,198 | 0.0% | 0.00% | – |
Q1 2021 | $16,000 | +6.7% | 5,198 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | -6.2% | 5,198 | 0.0% | 0.00% | – |
Q3 2020 | $16,000 | 0.0% | 5,198 | 0.0% | 0.00% | – |
Q2 2020 | $16,000 | -11.1% | 5,198 | 0.0% | 0.00% | – |
Q1 2020 | $18,000 | -25.0% | 5,198 | 0.0% | 0.00% | – |
Q4 2019 | $24,000 | -17.2% | 5,198 | 0.0% | 0.00% | – |
Q3 2019 | $29,000 | -12.1% | 5,198 | 0.0% | 0.00% | – |
Q2 2019 | $33,000 | +6.5% | 5,198 | 0.0% | 0.00% | – |
Q1 2019 | $31,000 | 0.0% | 5,198 | 0.0% | 0.00% | – |
Q4 2018 | $31,000 | +3.3% | 5,198 | 0.0% | 0.00% | – |
Q3 2018 | $30,000 | -6.2% | 5,198 | 0.0% | 0.00% | – |
Q2 2018 | $32,000 | -8.6% | 5,198 | 0.0% | 0.00% | – |
Q1 2018 | $35,000 | -7.9% | 5,198 | 0.0% | 0.00% | – |
Q4 2017 | $38,000 | +2.7% | 5,198 | 0.0% | 0.00% | – |
Q3 2017 | $37,000 | 0.0% | 5,198 | 0.0% | 0.00% | – |
Q2 2017 | $37,000 | +2.8% | 5,198 | 0.0% | 0.00% | – |
Q1 2017 | $36,000 | +24.1% | 5,198 | 0.0% | 0.00% | – |
Q4 2016 | $29,000 | – | 5,198 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
Renaissance Technologies | 555,763 | $1,050 | 0.00% |
Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
BlackRock Inc. | 110,990 | $209,771 | 0.00% |
Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
Citadel Advisors | 32,400 | $61,236 | 0.00% |
Citadel Advisors | 6,400 | $12,096 | 0.00% |
Citadel Advisors | 5,933 | $11,213 | 0.00% |